11 beta-hydroxysteroid dehydrogenase type 1 in obese children

11 beta-hydroxysteroid dehydrogenase type 1 in obese children

Opis bibliograficzny
Główni autorzy:	Wiegand, S, Richardt, A, Remer, T, Wudy, SA, Tomlinson, J, Grueters, A, Pm, S, Strasburger, C, Quinkler, M
Format:	Journal article
Wydane:	2007

Podobne zapisy

Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
od: Wiegand, S, i wsp.
Wydane: (2007)

Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
od: Stewart, P, i wsp.
Wydane: (2002)

The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
od: Tomlinson, J, i wsp.
Wydane: (2000)

11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes.
od: Morgan, SA, i wsp.
Wydane: (2010)

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
od: Tomlinson, J, i wsp.
Wydane: (2001)

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
od: Tomlinson, J, i wsp.
Wydane: (2002)

Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes.
od: Bujalska, I, i wsp.
Wydane: (2006)

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
od: Valsamakis, G, i wsp.
Wydane: (2004)

Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.
od: Quinkler, M, i wsp.
Wydane: (2004)

The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
od: Tomlinson, J, i wsp.
Wydane: (2002)

11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
od: Tomlinson, J
Wydane: (2005)

Cerebrospinal fluid production - A role for 11 beta-hydroxysteroid dehydrogenase type 1?
od: Rauz, S, i wsp.
Wydane: (2004)

11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
od: Swali, A, i wsp.
Wydane: (2008)

Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus.
od: Sinclair, A, i wsp.
Wydane: (2007)

Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
od: Maser, E, i wsp.
Wydane: (1997)

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
od: Tomlinson, J, i wsp.
Wydane: (2004)

Effects of glucocorticoids on fat mass and the therapeutic potential of targeting II beta-hydroxysteroid dehydrogenase type I in obesity
od: Tomlinson, J
Wydane: (2009)

Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
od: Bujalska, I, i wsp.
Wydane: (2005)

Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1.
od: Hult, M, i wsp.
Wydane: (2001)

Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.
od: Hult, M, i wsp.
Wydane: (2004)

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
od: Morgan, SA, i wsp.
Wydane: (2009)

The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
od: Tomlinson, J, i wsp.
Wydane: (2010)

A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
od: Bujalska, I, i wsp.
Wydane: (2008)

Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
od: Tomlinson, J, i wsp.
Wydane: (2004)

11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.
od: Gathercole, L, i wsp.
Wydane: (2013)

Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
od: Stewart, P, i wsp.
Wydane: (2009)

Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
od: Tomlinson, J, i wsp.
Wydane: (2005)

High-level production and optimization of monodispersity of 11beta-hydroxysteroid dehydrogenase type 1.
od: Elleby, B, i wsp.
Wydane: (2004)

Type 1 11beta-hydroxysteroid dehydrogenase as universal drug target in metabolic diseases?
od: Oppermann, U
Wydane: (2006)

Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
od: Tomlinson, J, i wsp.
Wydane: (2001)

Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
od: Tomlinson, J, i wsp.
Wydane: (2003)

11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome
od: Tomlinson, J, i wsp.
Wydane: (2005)

11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
od: Bujalska, I, i wsp.
Wydane: (2002)

Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.
od: Stulnig, T, i wsp.
Wydane: (2002)

Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics.
od: Hult, M, i wsp.
Wydane: (1998)

Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
od: Stimson, R, i wsp.
Wydane: (2009)

Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms.
od: Oppermann, U, i wsp.
Wydane: (1997)

Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets.
od: Davani, B, i wsp.
Wydane: (2000)

Cortisol Metabolism and Hepatic Expression of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Patients with Non Alcoholic Fatty Liver Disease.
od: Ahmed, A, i wsp.
Wydane: (2010)

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
od: Draper, N, i wsp.
Wydane: (2003)